iFlytek Healthcare Technology: Has applied for the conversion of 35,119,600 domestic shares into H shares.

iFlytek Healthcare Technology announced that the company intends to implement full circulation of H shares and has submitted an application to the China Securities Regulatory Commission to convert 35,119,600 domestic shares into H shares, accounting for approximately 29.0537% of the company's total issued share capital. After obtaining all relevant regulatory filings and/or approvals and complying with all applicable laws and regulations, such unlisted shares will be converted into H shares and become eligible for listing and trading on the Main Board of the Stock Exchange; pursuant to the Articles of Association, no further shareholders' meeting is required to approve the conversion and listing.